SV Health Investors

Venture Capital

SV Health Investors is a healthcare fund manager with approximately $2.7bn in assets under management and a transatlantic presence spanning biotechnology, dementia, and healthcare technology.

Website

Portfolio

companies

AUM

£2700M

under management

Portfolio companies

EyeBio

EyeBio develops a pipeline of novel therapies for retinal and eye diseases.

Recent investments

Series A14 November 2023

£52.0M

EyeBio secures £52m Series A extension from new and existing investors to advance retinal disease pipeline

BioTech

Bain Capital Life Sciences, Omega Funds and Vertex Ventures HC joined the financing round to support accelerated development of the company pipeline.

"We look forward to partnering with David Guyer and the world-class team at EyeBio to contribute to building a great company together"

— Bernard Davitian, Partner

EyeBio—New York, NY, USA

Bain Capital Life Sciences + 6 others